Corpus Intelligence IC Memo — PAM REHAB HOSP OF CENTENNIAL HILLS 2026-04-26 04:04 UTC
IC Memo — PAM REHAB HOSP OF CENTENNIAL HILLS
Investment Committee Memorandum | NV | 44 beds | Grade C | EBITDA uplift $2.6M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

PAM REHAB HOSP OF CENTENNIAL HILLS

CCN 293034 | nan, NV | 44 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

PAM REHAB HOSP OF CENTENNIAL HILLS is a 44-bed rural/critical access in nan, NV with $35.7M in net patient revenue and a 29.1% operating margin. The hospital serves a payer mix of 88.3% Medicare, 0.4% Medicaid, and 11.3% commercial.

Thesis: Turnaround. Our ML models identify $2.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 29.1% to 36.4% (+736bps).

Net Revenue HCRIS$35.7M
Current EBITDA COMPUTED$10.4M
Operating Margin COMPUTED29.1%
Occupancy HCRIS94.5%
Revenue / Bed COMPUTED$812K
Net-to-Gross HCRIS58.3%
Distress Probability ML43.1%

2. Market Context & Competitive Position

58
NV Hospitals
0.4%
State Median Margin
19
Comparable Hospitals

NV has 58 Medicare-certified hospitals with a median operating margin of 0.4%. The target's margin of 29.1% places it above the state median. Among 19 size-comparable peers (22-88 beds), the median margin is 4.4%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (22-88), prioritizing same-state peers. 19 hospitals in the comp set.

HospitalStateBedsRevenueMargin
PAM REHAB HOSP OF CENTENNIAL H (Target)NV44$35.7M29.1%
NORTHERN NEVADA MEDICAL CENTERNV88$150.8M10.5%
RENOWN SOUTH MEADOWS MED CTRNV78$91.0M4.0%
CARSON VALLEY MEDICAL CENTERNV23$84.3M6.8%
NORTHEASTERN NEVADA REGIONAL HNV59$84.2M15.5%
BANNER CHURCHILL COMMUNITY HOSNV25$69.2M6.8%
DIGINTY HEALTH ST ROSE DOMINICNV32$61.5M12.2%
HUMBOLDT GENERAL HOSPITALNV25$58.8M-37.3%
DIGNITY HEALTH REHABILITATION NV60$41.4M12.1%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.6M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$751K+210bp18mo
Cost to Collect4.5%2.5%$715K+200bp12mo
Denial Rate Reduction12.0%6.5%$708K+198bp12mo
A/R Days Reduction5200.0%3800.0%$435K+122bp9mo
Clean Claim Rate88.0%96.0%$23K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$751K
Cost to Collect
$715K
Denial Rate Reduction
$708K
A/R Days Reduction
$435K
Clean Claim Rate
$23K
Total EBITDA Uplift$2.6M
Current EBITDA$10.4M
+ RCM Uplift+$2.6M
Pro Forma EBITDA$13.0M
Current Margin29.1%
Pro Forma Margin36.4%
WC Released (1x)$1.4M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$16.0M$94.9M5.93x42.8%
Base (11x exit)10.0x11.0x$16.0M$109.5M6.85x46.9%
Bull Case9.0x11.0x$14.4M$123.4M8.58x53.7%
Bull (12x exit)9.0x12.0x$14.4M$138.9M9.65x57.4%
Bear Case11.0x10.0x$17.6M$76.5M4.35x34.2%
Bear (11x exit)11.0x11.0x$17.6M$89.9M5.11x38.6%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumHeavy Medicare dependenceMedicare comprises 88.3% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 19 hospitals with 22-88 beds
  • Same-state prioritization (n=20)
  • Comp margins: P25=-9.0% / P50=4.4% / P75=10.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.